Personal information

Tumor Virologist, Writer and Editor, Academician
India

Activities

Employment (4)

Indian Institute of Advanced Research: Gandhinagar, Gujarat, IN

2022-02-07 to present | Assistant Professor (Biotechnology and Bioengineering)
Employment
Source: Self-asserted source
Shuvomoy Banerjee

City of Hope: Lancaster, California, US

2017-11-28 to 2018-08-28 | Post-Doctoral Research Fellow (Immuno-Oncology)
Employment
Source: Self-asserted source
Shuvomoy Banerjee

Amity University: Noida, Uttar Pradesh, IN

2015-06-15 to 2017-06-15 | Asst. Professor (Virology and Immunology)
Employment
Source: Self-asserted source
Shuvomoy Banerjee

University of Pennsylvania: Philadelphia, PA, US

2010-04-01 to 2014-08-30 | PhD- Post-Doctoral Researcher (Microbiology)
Employment
Source: Self-asserted source
Shuvomoy Banerjee

Education and qualifications (4)

Bose Institute: Kolkata, West Bengal, IN

2004-10-12 to 2009-10-12 | PhD (Molecular medicine)
Qualification
Source: Self-asserted source
Shuvomoy Banerjee

University of Calcutta: Kolkata, West Bengal, IN

2002-03-15 to 2004-04-14 | Master of Science (Zoology)
Qualification
Source: Self-asserted source
Shuvomoy Banerjee

Council of Scientific and Industrial Research Human Resource Development Group: New Delhi, Delhi, IN

2003-12-28 to 2003-12-28 | UGC-NET (Life Science)
Education
Source: Self-asserted source
Shuvomoy Banerjee

University of Calcutta: Kolkata, West Bengal, IN

1999-03-23 to 2002-04-17 | Bachelor of Science (Zoology)
Qualification
Source: Self-asserted source
Shuvomoy Banerjee

Professional activities (12)

Encephalitis Society: Malton, North Yorkshire, GB

2020-09-25 to present | Professional Member (Medicine)
Membership
Source: Self-asserted source
Shuvomoy Banerjee

The Institute of Research Engineers and Doctors: New York, New York, US

2020-08-26 to present | Senior member
Membership
Source: Self-asserted source
Shuvomoy Banerjee

World Academy of Science Engineering and Technology: Istanbul, Istanbul, TR

2020-08-17 to present | Member (Science Engineering and Technology)
Membership
Source: Self-asserted source
Shuvomoy Banerjee

Society of Hematologic Oncology: Houston, Texas, US

2020-08-14 to present | Member (Hematologic Oncology)
Membership
Source: Self-asserted source
Shuvomoy Banerjee

Taif University: Taif, SA

2020-07-15 to present | Member (World Society for Virology (WSV) )
Membership
Source: Self-asserted source
Shuvomoy Banerjee

World Academy of Research in Science and Engineering: Tiruppur, Tamil Nadu, IN

2020-06-14 to present | Editorial Board Member (Science and Engineering)
Invited position
Source: Self-asserted source
Shuvomoy Banerjee

American Society for Microbiology: Washington, DC, US

2012-08-16 to present | Member (Microbiology)
Membership
Source: Self-asserted source
Shuvomoy Banerjee

Society of Biological Chemists : Kolkata, West Bengal, IN

2007-05-12 to present | Member (Chemical Biology)
Membership
Source: Self-asserted source
Shuvomoy Banerjee

The Zoological Society, kolkata: Kolkata, West Bengal, IN

2004-04-24 to present | Life member (zoology)
Membership
Source: Self-asserted source
Shuvomoy Banerjee

University of Pennsylvania: Philadelphia, PA, US

2010-04-01 to 2014-07-25 | Editorial Board member (Biomedical postdoctoral council)
Invited position
Source: Self-asserted source
Shuvomoy Banerjee

University of Calcutta: Kolkata, West Bengal, IN

2002-03-23 | Nakul Chandra De Memorial award (Zoology)
Distinction
Source: Self-asserted source
Shuvomoy Banerjee

University of Calcutta: Kolkata, West Bengal, IN

2001-03-15 | Aurobindo Guha Life Science Endowment Award (Zoology)
Distinction
Source: Self-asserted source
Shuvomoy Banerjee

Funding (1)

Delineating the molecular mechanisms of apoptotic inhibition by Epstein–Barr virus (EBV) via targeting RON-receptor tyrosine kinase during cancer progression

2016-03 to 2017-06 | Grant
Science and Engineering Research Board (New Delhi, New Delhi, IN)
GRANT_NUMBER:

YSS/2015/001334

Source: Self-asserted source
Shuvomoy Banerjee

Works (28)

STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity.

International journal of molecular sciences
2018-06-19 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

The regulatory role of protein phosphorylation in human gammaherpesvirus associated cancers.

Virologica Sinica
2017-10-30 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation.

PLoS pathogens
2017-07-24 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Crocetin exploits p53-induced death domain (PIDD) and FAS-associated death domain (FADD) proteins to induce apoptosis in colorectal cancer.

Scientific reports
2016-09-13 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

EBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation.

PLoS pathogens
2016-08-22 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

The Modulation of Apoptotic Pathways by Gammaherpesviruses.

Frontiers in microbiology
2016-04-27 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

The Role of Gammaherpesviruses in Cancer Pathogenesis.

Pathogens (Basel, Switzerland)
2016-02-06 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation.

Oncotarget
2015-10-01 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Kaposi's sarcoma-associated herpesvirus genome programming during the early stages of primary infection of peripheral blood mononuclear cells.

mBio
2014-12-16 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Regulation of the metastasis suppressor Nm23-H1 by tumor viruses.

Naunyn-Schmiedeberg's archives of pharmacology
2014-09-10 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation.

PLoS pathogens
2014-08-14 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1.

Journal of virology
2014-04-16 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.

Journal of virology
2014-04-02 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.

Journal of virology
2014-01-29 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.

Journal of virology
2014-01-15 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Epstein-barr virus and burkitt's lymphoma

Burkitt's Lymphoma
2013 | Book
EID:

2-s2.0-84952863161

Contributors: Banerjee, S.; Jha, H.C.; Cai, Q.; Robertson, E.S.
Source: Self-asserted source
Shuvomoy Banerjee via Scopus - Elsevier

IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation.

PLoS pathogens
2013-10-31 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.

Journal of virology
2013-08-28 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.

PLoS pathogens
2013-05-02 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Targeting RET to induce medullary thyroid cancer cell apoptosis: an antagonistic interplay between PI3K/Akt and p38MAPK/caspase-8 pathways.

Apoptosis : an international journal on programmed cell death
2013-05-01 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.

PLoS pathogens
2011-12-08 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer.

The Journal of biological chemistry
2011-10-19 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Gain of cellular adaptation due to prolonged p53 impairment leads to functional switchover from p53 to p73 during DNA damage in acute myeloid leukemia cells.

The Journal of biological chemistry
2010-07-30 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts.

Cellular & molecular immunology
2010-03-22 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.

Carcinogenesis
2009-12-07 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4 T cell survival: regulation by theaflavins.

PloS one
2009-10-08 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Contribution of p53-mediated Bax transactivation in theaflavin-induced mammary epithelial carcinoma cell apoptosis.

Apoptosis : an international journal on programmed cell death
2008-06-01 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.

Cancer research
2007-01-01 | Journal article
Source: Self-asserted source
Shuvomoy Banerjee
grade
Preferred source (of 2)‎

Peer review (4 reviews for 2 publications/grants)

Review activity for Environmental research. (2)
Review activity for Virusdisease. (2)